May 28, 2021 -- Sartorius plans to expand production facilities for purification products for vaccines and therapies at its facility in Ajdovscina, Slovenia.
The manufacturing and lab space will more than double from 3,000 sq m to 6,200 sq m. In 2021, the company will invest more than 400 million euros ($487.9 million U.S.) in manufacturing capacities around the world to keep up with demand.